ALBT (STOCKS)
Avalon GloboCare Corp. Common Stock
$0.432500
-0.024500 (-5.36%)
Prev close: $0.457000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Meng Li
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3.38M
- Employees
- 5
- P/E (TTM)
- -0.05
- P/B (TTM)
- -0.12
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Nonoperating Income/Loss | -$9.93M |
| Operating Income/Loss | -$7.59M |
| Income/Loss Before Equity Method Investments | $18.26M |
| Income/Loss From Continuing Operations After Tax | -$17.52M |
| Income/Loss From Continuing Operations Before Tax | -$17.52M |
| Income/Loss From Discontinued Operations Net Of Tax | -$742.10K |
| Income/Loss From Equity Method Investments | $392.68K |
| Income Tax Expense/Benefit | -$4.72M |
| Income Tax Expense/Benefit, Deferred | -$4.72M |
| Net Income/Loss | -$18.26M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$18.26M |
| Net Income/Loss Available To Common Stockholders, Basic | -$18.10M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | -$162.47K |
| Preferred Stock Dividends And Other Adjustments | -$162.47K |
| Basic Earnings Per Share | -$5.64 |
| Diluted Earnings Per Share | -$5.64 |
| Basic Average Shares | 3,210,779 |
| Diluted Average Shares | 3,210,779 |
| Assets | $23.40M |
| Current Assets | $1.50M |
| Noncurrent Assets | $21.90M |
| Fixed Assets | $727.00 |
| Intangible Assets | $2.16M |
| Other Non-current Assets | $19.75M |
| Liabilities | $14.17M |
| Current Liabilities | $14.15M |
| Noncurrent Liabilities | $23.52K |
| Equity | $9.23M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.23M |
| Liabilities And Equity | $23.40M |
| Net Cash Flow From Operating Activities | -$4.99M |
| Net Cash Flow From Operating Activities, Continuing | -$4.58M |
| Net Cash Flow From Operating Activities, Discontinued | -$407.43K |
| Net Cash Flow From Investing Activities | $1.05M |
| Net Cash Flow From Investing Activities, Continuing | $1.08M |
| Net Cash Flow From Investing Activities, Discontinued | -$35.87K |
| Net Cash Flow From Financing Activities | $1.40M |
| Net Cash Flow From Financing Activities, Continuing | $1.40M |
| Exchange Gains/Losses | -$9.02K |
| Net Cash Flow | -$5.03M |
| Net Cash Flow, Continuing | -$4.58M |
| Net Cash Flow, Discontinued | -$443.30K |
| Comprehensive Income/Loss | -$18.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$18.27M |
| Other Comprehensive Income/Loss | -$9.40K |